Sign in
4

Changes in Ownership

PharmaCyte Biotech, Inc. Filed Acc 0001683168-26-000148

CEO and President bought 100,000 shares at an average $0.80 ($80,476)

From the SEC's structured data for this filing

Trades in this filing

Silverman Joshua · CEO and President

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2026-01-05 Purchase : show line 1 in the form +30,000 $0.78 $23,493 346,250 D
2026-01-06 Purchase : show line 2 in the form +30,000 $0.79 $23,667 376,250 D
2026-01-07 Purchase : show line 3 in the form +40,000 $0.83 $33,316 416,250 D
Open-market purchases · 100,000 sh · avg $0.80 · $80,476
Loading xslF345X05/ownership.xml…